Literature DB >> 6838088

Transdermal scopolamine and toxic psychosis.

K J Rodysill, J B Warren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6838088     DOI： 10.7326/0003-4819-98-4-561_2

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  4 in total

Review 1.  Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications.

Authors:  Zohar Nachum; Avi Shupak; Carlos R Gordon
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

2.  Psychosis due to transdermally administered scopolamine.

Authors:  G W MacEwan; R A Remick; J A Noone
Journal:  CMAJ       Date:  1985-09-01       Impact factor: 8.262

Review 3.  Drug-induced psychiatric disorders and their management.

Authors:  L E Hollister
Journal:  Med Toxicol       Date:  1986 Nov-Dec

Review 4.  Transdermal hyoscine (Scopolamine). A preliminary review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  S P Clissold; R C Heel
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.